Healthcare • Pharmaceutical Retailers
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PETS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 3
49 filers reported a long position in PETS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $2.2M | 1.1M | -4.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.6M | 827.4K | -0.5% |
| BlackRock, Inc. | $1.1M | 568.3K | +3% |
| FEDERATED HERMES, INC. | $407.4K | 212.2K | -68.2% |
| GEODE CAPITAL MANAGEMENT, LLC | $391.9K | 204.1K | -7.9% |
| STEEL PARTNERS HOLDINGS L.P. | $371.8K | 193.7K | Unchanged |
| UBS Group AG | $265.6K | 138.3K | -40.8% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $250K | 129.9K | +8.2% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232.4K | 121K | -8.8% |
| Rangeley Capital, LLC | $232.3K | 121K | +10.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.